Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)
Completed
- Conditions
- Interstitial Cystitis
- Registration Number
- NCT00704457
- Lead Sponsor
- Kenneth Peters, MD
- Brief Summary
Urine will be collected and sent to the University of Maryland. Urines will be analyzed for urine markers.
- Detailed Description
Urine will be collected and flash frozen in liquid nitrogen then placed in a -70 C freezer. All urine will be collected and stored until the final follow-up is complete. The urine samples will then be sent as a single batch to the Department of Infectious Disease, University of Maryland. Urines will be assayed in a blinded fashion and a written report of the levels of each of the 3 urine markers will be sent to Beaumont Hospital. Change in urine marker levels will be analyzed and correlated with change in symptom scores.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 11
Inclusion Criteria
- Patients will be drawn from Dr. Peters patient base that covers Southeast Michigan.
Exclusion Criteria
- Male
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The purpose of this study is measure urine biomarkers levels in patients with interstitial cystitis who have elected to undergo sacral nerve stimulation as a treatment modality for their disease. 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Beaumont Hospital - Royal Oak
🇺🇸Royal Oak, Michigan, United States